Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 27, 2009
Grant Date -
N/A
app pub date -
Jun 3, 2008
filing date -
Jun 3, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed herein is a method for treating a patient with Quazepam that reduces the risk of an adverse interaction between the Quazepam and drug that is a substrate of the cytochrome P450 enzyme isoform 2B6 (CYP2B6 substrate drug), e.g., Bupropion. The method includes determining if the patient to be treated with Quazepam is being treated with a CYP2B6 substrate drug, and prescribing or treating the patient with Quazepam based on the determination.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully